Abstract: Described herein are compounds and compositions for modulating kinase activity, and methods for modulating kinase activity using the compounds and compositions. Also described herein are methods of using the compounds and/or compositions in the treatment and prevention of a variety of diseases and unwanted conditions in subjects.

Abstract: The invention provides pyrrole-containing compounds and methods of use thereof. Kits and pharmaceutical compositions comprising the pyrrole compounds of the invention are also provided. The compounds and compositions disclosed herein are preferably used in the treatment of neurodegenerative diseases, cardiovascular diseases, proliferative diseases, neuroinflammatory disorders, vascular disorders with an inflammatory component, and visual disorders. In particular, methods and compositions for the treatment of stroke are disclosed herein.

Abstract: The invention provides methods and compositions for treating conditions mediated by flt-3 wherein derivatives of amide compounds are employed. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.

Abstract: The invention provides methods and compositions for treating conditions mediated by PDGFR wherein derivatives of amide compounds are employed. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.

Abstract: Described herein are compounds and compositions for modulating kinase activity, and methods for modulating kinase activity using the compounds and compositions. Also described herein are methods of using the compounds and/or compositions in the treatment and prevention of a variety of diseases and unwanted conditions in subjects.

Abstract: The invention provides methods and compositions for treating conditions mediated by c-kit wherein derivatives of amide compounds are employed. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.

Abstract: The invention provides methods and compositions for treating conditions mediated by various kinases wherein derivatives of urea compounds are employed. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.

Abstract: Described herein are compounds and compositions for modulating kinase activity, and methods for modulating kinase activity using the compounds and compositions. Also described herein are methods of using the compounds and/or compositions in the treatment and prevention of a variety of diseases and unwanted conditions in subjects.

Abstract: Provided herein are linker compounds and conjugates that include the linker compounds. In one embodiment, the linker compounds comprise 2 or 3 residues of 6-aminohexanoic acid and optionally 7-10 residues of polyethyleneglycol (PEG). The linker compounds are useful in forming conjugates with one or more components useful in biopharmaceutical or bioanalytical applications. In particular, the biopharmaceutically useful compounds are kinase inhibitors. The conjugates described herein have utility in a variety of diagnostic, separation, and therapeutic applications.

Abstract: The invention provides methods and compositions for treating conditions mediated by abl wherein derivatives of amide compounds are employed. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.

Abstract: A transparent electrically conductive device which includes an indium tin oxide film is improved by providing an indium tin oxide film which contains a graded stack of individual indium tin oxide layers wherein the atomic percent of tin in the layers can be individually selected. Each indium tin oxide layer of the film contains 1-99 atomic percent tin. Each layer is made by a physical vapor deposition process or by sputter coating. Preferably the film which contains a plurality of indium tin oxide layers is applied to a transparent flexible substrate such as a polymeric sheet. Optional primer layers, hardcoat layers and topcoat layers may be included in the device.

Abstract: A transparent electrically conductive device which includes an indium tin oxide film is improved by providing an indium tin oxide film which contains a graded stack of individual indium tin oxide layers wherein the atomic percent of tin in the layers can be individually selected. Each indium tin oxide layer of the film contains 1-99 atomic percent tin. Each layer is made by a physical vapor deposition process or by sputter coating. Preferably the film which contains a plurality of indium tin oxide layers is applied to a transparent flexible substrate such as a polymeric sheet. Optional primer layers, hardcoat layers and topcoat layers may be included in the device.

Abstract: The invention affords a system and method for programming a data processor having a microprocessor and reconfigurable logic, to attain high-speed performance while maintaining compatibility with current software programming practices by providing an API that makes the details of the interaction between the microprocessor and the reconfigurable logic units transparent to the compiler. The API virtualizes operations implemented within the reconfigurable logic unit as reconfigurable logic instructions (RL-instructions) which can be scheduled by the compiler in a manner similar to microprocessor instructions. The API provides methods for the microprocessor to configure the reconfigurable logic unit, transmit data to the reconfigurable logic unit, receive data from the reconfigurable logic unit, and otherwise interact with the reconfigurable logic unit.